Investor Presentation: First Nine Months of 2020

85 Investor presentation First nine months of 2020 Insulin market size and volume market share in EMEA Insulin market share and market size (DKK billion) Total 47% Long- acting 38% Fast- 56% 11 acting 71% Premix 4 18 Novo Nordisk® Market growth A Market share Insulin volume: market share 80% 37 3% +1.0% 12% 10% 60% 6% +1.7% 8% 47% 6% 40% 4% 4% +0.9% 2% 4% 20% -0.6% +1.6% 0% Aug 2017 -8% -0.7% NN market share 0% -2% -4% Aug 2020 44% Human 4 Novo Nordisk Competitors Source: IQVIA, Aug 2020, LHS graph - Value, RHS Graph - Volume, MAT, Europe, Middle East & Africa, Share of growth not depicted due to too high numbers; NN: Novo Nordisk -Market growth (right axis) NN growth (right axis)

View entire presentation